Blood pressure stability in hemodialysis patients confers a survival advantage: Results from a large retrospective cohort study

Kidney International

Volumn 81, Issue 6, 2012, Pages 548-558

  Raimann, Jochen G ^a,b   Usvyat, Len A ^a   Thijssen, Stephan ^a,b   Kotanko, Peter ^a,b   Rogus, John ^c   Lacson Jr , Eduardo ^c   Levin, Nathan W ^a,b  

^a RENAL RESEARCH INSTITUTE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

Author keywords

blood pressure; cardiovascular disease; chronic dialysis; hemodialysis; mortality risk

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 84857783397     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.426     Document Type: Article

References (24)

1. Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297.
2. Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913. (Pubitemid 35472129)
3. Agarwal R, Nissenson AR, Batlle D et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 2003; 115: 291-297. (Pubitemid 37088191)
4. Rocco MV, Yan G, Heyka RJ et al. Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. Am J Nephrol 2001; 21: 280-288. (Pubitemid 32757311)
5. Levin NW, Kotanko P, Eckardt KU et al. Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int 2009; 77: 273-284.
6. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006; 48(Suppl 1): S2-90.
7. Fletcher AE, Beevers DG, Bulpitt CJ et al. The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP). J Hum Hypertens 1988; 2: 11-15.
8. Waller PC, Isles CG, Lever AF et al. Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens 1988; 2: 7-10.
9. Protogerou AD, Safar ME, Iaria P et al. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 2007; 50: 172-180. (Pubitemid 46986039)
10. Messerli FH, Mancia G, Conti CR et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006; 144: 884-893. (Pubitemid 46768128)
11. Samuelsson O, Wilhelmsen L, Andersson OK et al. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Goteborg, Sweden. JAMA 1987; 258: 1768-1776. (Pubitemid 18092204)
12. Alderman MH, Ooi WL, Madhavan S et al. Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA 1989; 262: 920-924. (Pubitemid 19208949)
13. Cooper SP, Hardy RJ, Labarthe DR et al. The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-Up Program. Am J Epidemiol 1988; 127: 387-403. (Pubitemid 18056390)
14. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987; 1: 581-584.
15. Bangalore S, Messerli FH, Wun CC et al. J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) trial. Eur Heart J 2010; 31: 2897-2908.
16. Li Z, Lacson Jr E, Lowrie EG et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006; 48: 606-615. (Pubitemid 44425376)
17. Myers OB, Adams C, Rohrscheib MR et al. Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol 2010; 21: 1970-1978.
18. Zager PG, Nikolic J, Brown RH et al. 'U' curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 1998; 54: 561-569. (Pubitemid 28357420)
19. Agarwal R, Sinha AD. Cardiovascular protection with antihypertensive drugs in dialysis patients. Systematic review and meta-analysis. Hypertension 2009; 53: 860-866.
20. Heerspink HJ, Ninomiya T, Zoungas S et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet 2009; 373: 1009-1015.
21. Tepel M, Giet MV, Park A et al. Association of calcium channel blockers and mortality in haemodialysis patients. Clin Sci (Lond) 2002; 103: 511-515. (Pubitemid 35305636)
22. Raimann J, Li L, Tyagi S et al. A fresh look at dry weight. Hemodial Int 2008; 12: 395-405.
23. Agarwal R, Peixoto AJ, Santos SF et al. Pre-and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2006; 1: 389-398.
24. Centers for Disease Control and Prevention (U.S.), Centers for Medicare & Medicaid Services (U.S.) In: Official (ed). ICD-9-CM International Classification of Diseases, Ninth Revision, Clinical Modification, 6th edn. U.S. Dept. of Health and Human Services and the Centers for Medicare and Medicaid Services, 2008, pp 1 CD-ROM.